Gentian Diagnostics
Vær den første som følger denne virksomhed
Gentian Diagnostics is a Norwegian company that develops various products in healthcare. Examples are diagnostic tests with the goal of developing and streamlining diagnostic treatment, which includes treatment of cancer and cardiovascular disease. A large part of the business includes R&D development. The company was founded in 1998 and is headquartered in Moss.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
GENT
Daglig lav / høj pris
-
Markedsværdi
-
Aktieomsætning
-
Volumen
-
Finanskalender
Generalforsamling
29.04.2024
Delårsrapport
30.04.2024
Delårsrapport
29.08.2024
Delårsrapport
31.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Vatne Equity AS | 13,7 % | 13,7 % |
Kvantia AS | 10,5 % | 10,5 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Gentian Diagnostics: CEO resignation
Gentian Diagnostics: Annual report 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools